Literature DB >> 16699382

Correlates of health-related quality of well-being in older patients with schizophrenia.

Dinesh Mittal1, C Ervin Davis, Colin Depp, Jeffrey M Pyne, Shahrokh Golshan, Thomas L Patterson, Dilip V Jeste.   

Abstract

Research on correlates of health-related quality of life (HRQOL) among older patients with schizophrenia has been very limited. This study evaluated the relative impact of positive, negative, and depressive symptoms, movement disorders, and cognitive impairment on HRQOL among middle-aged and older patients with schizophrenia or schizoaffective disorder. Participants were 199 patients aged 45 to 85 years. The study was cross-sectional. The primary outcome measure was the Quality of Well-Being scale, and correlates were measures of positive and negative symptoms, depression, abnormal movements, and cognitive performance. Severity of depressive symptoms and of cognitive impairment correlated significantly with HRQOL and independently affected HRQOL scores. The initiation/perseveration subscale of the Dementia Rating Scale had the largest impact. These findings suggest that depressive symptoms and cognitive functioning should be part of the routine assessment of older people with schizophrenia and may be targets for psychopharmacological and psychosocial interventions to improve HRQOL.

Entities:  

Mesh:

Year:  2006        PMID: 16699382     DOI: 10.1097/01.nmd.0000217881.94887.12

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  8 in total

1.  The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia.

Authors:  M Riedel; I Spellmann; R Schennach-Wolff; M Obermeier; R Musil
Journal:  Qual Life Res       Date:  2010-10-05       Impact factor: 4.147

2.  Subjective and objective quality of life in schizophrenia.

Authors:  Jenille M Narvaez; Elizabeth W Twamley; Christine L McKibbin; Robert K Heaton; Thomas L Patterson
Journal:  Schizophr Res       Date:  2007-10-04       Impact factor: 4.939

Review 3.  Management of schizophrenia in late life with antipsychotic medications: a qualitative review.

Authors:  Takefumi Suzuki; Gary Remington; Hiroyuki Uchida; Tarek K Rajji; Ariel Graff-Guerrero; David C Mamo
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

4.  "We're not just sitting on the periphery": a staff perspective of physical activity in older adults with schizophrenia.

Authors:  Heather Leutwyler; Erin M Hubbard; Dilip V Jeste; Sophia Vinogradov
Journal:  Gerontologist       Date:  2012-08-30

5.  Medication adherence among older adults with schizophrenia.

Authors:  Heather C Leutwyler; Patrick J Fox; Margaret Wallhagen
Journal:  J Gerontol Nurs       Date:  2013-01-18       Impact factor: 1.254

6.  Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.

Authors:  John Kasckow; Nicole Lanouette; Thomas Patterson; Ian Fellows; Shahrokh Golshan; Ellen Solorzano; Sidney Zisook
Journal:  Int J Geriatr Psychiatry       Date:  2010-02       Impact factor: 3.485

7.  Association between schizophrenia symptoms and neurocognition on mobility in older adults with schizophrenia.

Authors:  H Leutwyler; E Hubbard; D Jeste; B Miller; S Vinogradov
Journal:  Aging Ment Health       Date:  2014-04-04       Impact factor: 3.658

8.  A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study.

Authors:  Nicolas Hoertel; Léa Rotenberg; Carlos Blanco; Vincent Camus; Caroline Dubertret; Véronique Charlot; Franck Schürhoff; Pierre Vandel; Frédéric Limosin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-05-15       Impact factor: 4.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.